Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Envista Holdings Corporation (NVST : NYSE)
 
 • Company Description   
Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California.

Number of Employees: 11,200

 
 • Price / Volume Information   
Yesterday's Closing Price: $42.03 Daily Weekly Monthly
20 Day Moving Average: 2,006,549 shares
Shares Outstanding: 162.62 (millions)
Market Capitalization: $6,834.83 (millions)
Beta: 1.64
52 Week High: $52.03
52 Week Low: $37.60
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.65% 7.38%
12 Week -11.25% -2.44%
Year To Date -6.72% 14.13%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
200 S. KRAEMER BLVD. BUILDING E
-
BREA,CA 92821
USA
ph: 714-817-7000
fax: 714-817-5450
ir@envistaco.com http://www.envistaco.com
 
 • General Corporate Information   
Officers
Amir Aghdaei - President; Chief Executive Officer
Scott Huennekens - Chairman of the Board
Howard H. Yu - Senior Vice President and Chief Financial Officer
Kari-Lyn Moore - Vice President and Chief Accounting Officer
Wendy Carruthers - Director

Peer Information
Envista Holdings Corporation (BJCT)
Envista Holdings Corporation (CADMQ)
Envista Holdings Corporation (APNO)
Envista Holdings Corporation (UPDC)
Envista Holdings Corporation (IMTIQ)
Envista Holdings Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 29415F104
SIC: 3843
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
Share - Related Items
Shares Outstanding: 162.62
Most Recent Split Date: (:1)
Beta: 1.64
Market Capitalization: $6,834.83 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.46 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $2.02 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 13.15% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 20.81
Trailing 12 Months: 22.01
PEG Ratio: 1.58
Price Ratios
Price/Book: 1.70
Price/Cash Flow: 13.47
Price / Sales: 2.60
EPS Growth
vs. Year Ago Period: -12.96%
vs. Previous Quarter: 2.17%
Sales Growth
vs. Year Ago Period: -10.97%
vs. Previous Quarter: -3.13%
ROE
03/31/22 - 8.54
12/31/21 - 8.96
09/30/21 - 9.52
ROA
03/31/22 - 5.19
12/31/21 - 5.40
09/30/21 - 5.54
Current Ratio
03/31/22 - 1.52
12/31/21 - 1.52
09/30/21 - 1.39
Quick Ratio
03/31/22 - 1.30
12/31/21 - 1.30
09/30/21 - 1.18
Operating Margin
03/31/22 - 12.91
12/31/21 - 12.93
09/30/21 - 13.04
Net Margin
03/31/22 - 13.06
12/31/21 - 12.57
09/30/21 - 13.02
Pre-Tax Margin
03/31/22 - 10.00
12/31/21 - 10.14
09/30/21 - 11.64
Book Value
03/31/22 - 24.79
12/31/21 - 25.15
09/30/21 - 24.46
Inventory Turnover
03/31/22 - 3.84
12/31/21 - 3.82
09/30/21 - 3.64
Debt-to-Equity
03/31/22 - 0.22
12/31/21 - 0.22
09/30/21 - 0.22
Debt-to-Capital
03/31/22 - 17.87
12/31/21 - 17.88
09/30/21 - 18.36
 

Powered by Zacks Investment Research ©